Quantitative analysis of the anti-proliferative activity of combinations of selected iron-chelating agents and clinically used anti-neoplastic drugs.
Recent studies have demonstrated that several chelators possess marked potential as potent anti-neoplastic drugs and as agents that can ameliorate some of the adverse effects associated with standard chemotherapy. Anti-cancer treatment employs combinations of several drugs that have different mechan...
Main Authors: | Eliska Potuckova, Hana Jansova, Miloslav Machacek, Anna Vavrova, Pavlina Haskova, Lucie Tichotova, Vera Richardson, Danuta S Kalinowski, Des R Richardson, Tomas Simunek |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2014-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24586383/pdf/?tool=EBI |
Similar Items
-
In Vitro Characterization of the Pharmacological Properties of the Anti-Cancer Chelator, Bp4eT, and Its Phase I Metabolites.
by: Eliška Potůčková, et al.
Published: (2015-01-01) -
Structure-activity relationships of novel salicylaldehyde isonicotinoyl hydrazone (SIH) analogs: iron chelation, anti-oxidant and cytotoxic properties.
by: Eliška Potůčková, et al.
Published: (2014-01-01) -
Catalytic inhibitors of topoisomerase II differently modulate the toxicity of anthracyclines in cardiac and cancer cells.
by: Anna Vavrova, et al.
Published: (2013-01-01) -
Examination of diverse iron-chelating agents for the protection of differentiated PC12 cells against oxidative injury induced by 6-hydroxydopamine and dopamine
by: Pavlína Hašková, et al.
Published: (2022-06-01) -
Macrophage and angiogenesis intensity within proliferative non neoplastic and neoplastic oral lesions
by: Janti Sudiono, et al.
Published: (2018-11-01)